0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drugs for Treating Mental Disorders Key Trends and Opportunities to 2027
Published Date: July 2021
|
Report Code: QYRE-Auto-32A2048
Home | Market Reports | Health | Mental Health
Global Drugs for Treating Mental Disorders Key Trends and Opportunities to 2027

Global Drugs for Treating Mental Disorders Key Trends and Opportunities to 2027

Code: QYRE-Auto-32A2048
Report
July 2021
191 Pages
QYResearch
Region: Global, Turkey, Saudi Arabia, UAE, Argentina, North America, Europe, Canada, Germany, France, Brazil, South Korea, Vietnam, Mexico, Australia, Indonesia, Thailand, Malaysia, Philippines, China, Japan, Italy,
Description
Table of Content
Tables & Figures
Market Analysis and Insights: Global Drugs for Treating Mental Disorders Market
In 2020, the global Drugs for Treating Mental Disorders market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
Global Drugs for Treating Mental Disorders Scope and Market Size
Drugs for Treating Mental Disorders market is segmented by companies, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drugs for Treating Mental Disorders market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on market size and forecast for the period 2016-2027.

Segment by Type, the Drugs for Treating Mental Disorders market is segmented into Tablets, Capsule, Injection, Solution, Other, etc.

Segment by Application, the Drugs for Treating Mental Disorders market is segmented into Antipsychotics, Antidepressants, Antianxiety (Anxiolyitcs), Anti-Seizure Medications, Stimulants, Cognitive Disorders And Dementia, Sleep Disorder Treatments, Substance Abuse Treatments, Hypnosis And Tranquilizers, etc.
Regional and Country-level Analysis
The report offers exhaustive assessment of different region-wise and country-wise Drugs for Treating Mental Disorders markets such as the U.S., Canada, Germany, France, the U.K., Italy, Russia, China, Japan, South Korea, Taiwan, India, Australia, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Argentina, Saudi Arabia, UAE, Turkey, etc.
The report includes country-wise and region-wise market size for the period 2016-2027, by countries (regions), by Type, and by Application, as well as by players for North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Competitive Landscape and Drugs for Treating Mental Disorders Market Share Analysis
Drugs for Treating Mental Disorders market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2016-2021. Details included are company description, major business, company total revenue and revenue generated in Drugs for Treating Mental Disorders business, the date to enter into the Drugs for Treating Mental Disorders market, Drugs for Treating Mental Disorders product introduction, recent developments, etc.
The major vendors include Johnson and Johnson, Pfizer, Eli Lilly, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, Teva Pharmaceutical, Dr. Reddy's Laboratories, Apotex Inc., Mylan Pharmaceuticals, Par Pharmaceutical, Aurobindo Pharma, Torrent Pharmaceuticals, Jubilant Lifesciences, Sun Pharmaceutical, Sandoz (Novartis), Hansoh Pharmaceutical, WATSON Pharmaceuticals, Zhejiang Langhua Pharmaceuticals, Forest Laboratories, etc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Treating Mental Disorders Market Size by Type: 2016 VS 2021 VS 2027
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Injection
1.2.5 Solution
1.2.6 Other
1.3 Market by Application
1.3.1 Global Drugs for Treating Mental Disorders Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Antipsychotics
1.3.3 Antidepressants
1.3.4 Antianxiety (Anxiolyitcs)
1.3.5 Anti-Seizure Medications
1.3.6 Stimulants
1.3.7 Cognitive Disorders And Dementia
1.3.8 Sleep Disorder Treatments
1.3.9 Substance Abuse Treatments
1.3.10 Hypnosis And Tranquilizers
1.3.11 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trend
2.1 Global Drugs for Treating Mental Disorders Market Perspective (2016-2027)
2.2 Global Drugs for Treating Mental Disorders Growth Trends by Regions
2.2.1 Drugs for Treating Mental Disorders Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Drugs for Treating Mental Disorders Historic Market Size by Regions (2016-2021)
2.2.3 Drugs for Treating Mental Disorders Forecasted Market Size by Regions (2022-2027)
2.3 Industry Trends and Growth Strategy
2.3.1 Drugs for Treating Mental Disorders Industry Trends
2.3.2 Drugs for Treating Mental Disorders Market Drivers
2.3.3 Drugs for Treating Mental Disorders Market Challenges
2.3.4 Drugs for Treating Mental Disorders Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Treating Mental Disorders Players by Market Size
3.1.1 Players Covered: Ranking by Drugs for Treating Mental Disorders Revenue
3.1.2 Global Top Drugs for Treating Mental Disorders Players by Revenue (2016-2021)
3.1.3 Global Drugs for Treating Mental Disorders Revenue Market Share by Players (2016-2021)
3.1.4 Global Drugs for Treating Mental Disorders Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Drugs for Treating Mental Disorders Market Concentration Ratio
3.2.1 Global Drugs for Treating Mental Disorders Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 5 and Top 10 Players by Drugs for Treating Mental Disorders Revenue in 2020
3.3 Drugs for Treating Mental Disorders Key Players Head office and Area Served
3.4 Key Players Drugs for Treating Mental Disorders Product Solution and Service
3.5 Date of Enter into Drugs for Treating Mental Disorders Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Global Drugs for Treating Mental Disorders Breakdown Data by Type (2016-2027)
4.1 Global Drugs for Treating Mental Disorders Historic Market Size by Type (2016-2021)
4.2 Global Drugs for Treating Mental Disorders Forecasted Market Size by Type (2022-2027)
5 Global Drugs for Treating Mental Disorders Breakdown Data by Application (2016-2027)
5.1 Global Drugs for Treating Mental Disorders Historic Market Size by Application (2016-2021)
5.2 Drugs for Treating Mental Disorders Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Drugs for Treating Mental Disorders Market Size (2016-2027)
6.2 Key Drugs for Treating Mental Disorders Players Market Share in North America (2020-2021)
6.3 North America Drugs for Treating Mental Disorders Market Size by Country
6.3.1 North America Drugs for Treating Mental Disorders Market Size by Country (2016-2021)
6.3.2 North America Drugs for Treating Mental Disorders Market Size Forecast by Country (2022-2027)
6.4 U.S. Market Size Analysis
6.4.1 U.S. Drugs for Treating Mental Disorders Market Size (2016-2027)
6.4.2 U.S. Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
6.4.3 U.S. Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
6.5 Canada Market Size Analysis
6.5.1 Canada Drugs for Treating Mental Disorders Market Size (2016-2027)
6.5.2 Canada Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
6.5.3 Canada Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
7 Europe
7.1 Europe Drugs for Treating Mental Disorders Market Size (2016-2027)
7.2 Key Drugs for Treating Mental Disorders Players Market Share in Europe (2020-2021)
7.3 Europe Drugs for Treating Mental Disorders Market Size by Country
7.3.1 Europe Drugs for Treating Mental Disorders Market Size by Country (2016-2021)
7.3.2 Europe Drugs for Treating Mental Disorders Market Size Forecast by Country (2022-2027)
7.4 Germany Market Size Analysis
7.4.1 Germany Drugs for Treating Mental Disorders Market Size (2016-2027)
7.4.2 Germany Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
7.4.3 Germany Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
7.5 France Market Size Analysis
7.5.1 France Drugs for Treating Mental Disorders Market Size (2016-2027)
7.5.2 France Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
7.5.3 France Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
7.6 U.K. Market Size Analysis
7.6.1 U.K. Drugs for Treating Mental Disorders Market Size (2016-2027)
7.6.2 U.K. Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
7.6.3 U.K. Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
7.7 Italy Market Size Analysis
7.7.1 Italy Drugs for Treating Mental Disorders Market Size (2016-2027)
7.7.2 Italy Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
7.7.3 Italy Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
7.8 Russia Market Size Analysis
7.8.1 Russia Drugs for Treating Mental Disorders Market Size (2016-2027)
7.8.2 Russia Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
7.8.3 Russia Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Treating Mental Disorders Market Size (2016-2027)
8.2 Key Drugs for Treating Mental Disorders Players Market Share in Asia-Pacific (2020-2021)
8.3 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Region
8.3.1 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Region (2016-2021)
8.3.2 Asia-Pacific Drugs for Treating Mental Disorders Market Size Forecast by Region (2022-2027)
8.4 China Market Size Analysis
8.4.1 China Drugs for Treating Mental Disorders Market Size (2016-2027)
8.4.2 China Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
8.4.3 China Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
8.5 Japan Market Size Analysis
8.5.1 Japan Drugs for Treating Mental Disorders Market Size (2016-2027)
8.5.2 Japan Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
8.5.3 Japan Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
8.6 South Korea Market Size Analysis
8.6.1 South Korea Drugs for Treating Mental Disorders Market Size (2016-2027)
8.6.2 South Korea Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
8.6.3 South Korea Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
8.7 India Market Size Analysis
8.7.1 India Drugs for Treating Mental Disorders Market Size (2016-2027)
8.7.2 India Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
8.7.3 India Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
8.8 Australia Market Size Analysis
8.8.1 Australia Drugs for Treating Mental Disorders Market Size (2016-2027)
8.8.2 Australia Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
8.8.3 Australia Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
8.9 Taiwan Market Size Analysis
8.9.1 Taiwan Drugs for Treating Mental Disorders Market Size (2016-2027)
8.9.2 Taiwan Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
8.9.3 Taiwan Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
8.10 Indonesia Market Size Analysis
8.10.1 Indonesia Drugs for Treating Mental Disorders Market Size (2016-2027)
8.10.2 Indonesia Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
8.10.3 Indonesia Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
8.11 Thailand Market Size Analysis
8.11.1 Thailand Drugs for Treating Mental Disorders Market Size (2016-2027)
8.11.2 Thailand Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
8.11.3 Thailand Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
8.12 Malaysia Market Size Analysis
8.12.1 Malaysia Drugs for Treating Mental Disorders Market Size (2016-2027)
8.12.2 Malaysia Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
8.12.3 Malaysia Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
8.13 Philippines Market Size Analysis
8.13.1 Philippines Drugs for Treating Mental Disorders Market Size (2016-2027)
8.13.2 Philippines Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
8.13.3 Philippines Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
8.14 Vietnam Market Size Analysis
8.14.1 Vietnam Drugs for Treating Mental Disorders Market Size (2016-2027)
8.14.2 Vietnam Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
8.14.3 Vietnam Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
9 Latin America
9.1 Latin America Drugs for Treating Mental Disorders Market Size (2016-2027)
9.2 Key Drugs for Treating Mental Disorders Players Market Share in Latin America (2020-2021)
9.3 Latin America Drugs for Treating Mental Disorders Market Size by Country
9.3.1 Latin America Drugs for Treating Mental Disorders Market Size by Country (2016-2021)
9.3.2 Latin America Drugs for Treating Mental Disorders Market Size Forecast by Country (2022-2027)
9.4 Mexico Market Size Analysis
9.4.1 Mexico Drugs for Treating Mental Disorders Market Size (2016-2027)
9.4.2 Mexico Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
9.4.3 Mexico Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
9.5 Brazil Market Size Analysis
9.5.1 Brazil Drugs for Treating Mental Disorders Market Size (2016-2027)
9.5.2 Brazil Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
9.5.3 Brazil Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
9.6 Argentina Market Size Analysis
9.6.1 Argentina Drugs for Treating Mental Disorders Market Size (2016-2027)
9.6.2 Argentina Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
9.6.3 Argentina Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Treating Mental Disorders Market Size (2016-2027)
10.2 Key Drugs for Treating Mental Disorders Players Market Share in Middle East & Africa (2020-2021)
10.3 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Country
10.3.1 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Country (2016-2021)
10.3.2 Middle East & Africa Drugs for Treating Mental Disorders Market Size Forecast by Country (2022-2027)
10.4 Turkey Market Size Analysis
10.4.1 Turkey Drugs for Treating Mental Disorders Market Size (2016-2027)
10.4.2 Turkey Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
10.4.3 Turkey Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
10.5 Saudi Arabia Market Size Analysis
10.5.1 Saudi Arabia Drugs for Treating Mental Disorders Market Size (2016-2027)
10.5.2 Saudi Arabia Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
10.5.3 Saudi Arabia Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
10.6 UAE Market Size Analysis
10.6.1 UAE Drugs for Treating Mental Disorders Market Size (2016-2027)
10.6.2 UAE Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
10.6.3 UAE Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Details
11.1.2 Johnson and Johnson Business Overview and Its Total Revenue
11.1.3 Johnson and Johnson Drugs for Treating Mental Disorders Introduction
11.1.4 Johnson and Johnson Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.1.5 Johnson and Johnson Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview and Its Total Revenue
11.2.3 Pfizer Drugs for Treating Mental Disorders Introduction
11.2.4 Pfizer Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview and Its Total Revenue
11.3.3 Eli Lilly Drugs for Treating Mental Disorders Introduction
11.3.4 Eli Lilly Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview and Its Total Revenue
11.4.3 GlaxoSmithKline Drugs for Treating Mental Disorders Introduction
11.4.4 GlaxoSmithKline Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.4.5 GlaxoSmithKline Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview and Its Total Revenue
11.5.3 AstraZeneca Drugs for Treating Mental Disorders Introduction
11.5.4 AstraZeneca Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.5.5 AstraZeneca Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
11.6.3 Bristol-Myers Squibb Drugs for Treating Mental Disorders Introduction
11.6.4 Bristol-Myers Squibb Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Details
11.7.2 Teva Pharmaceutical Business Overview and Its Total Revenue
11.7.3 Teva Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.7.4 Teva Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.7.5 Teva Pharmaceutical Recent Development
11.8 Dr. Reddy's Laboratories
11.8.1 Dr. Reddy's Laboratories Company Details
11.8.2 Dr. Reddy's Laboratories Business Overview and Its Total Revenue
11.8.3 Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Introduction
11.8.4 Dr. Reddy's Laboratories Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.8.5 Dr. Reddy's Laboratories Recent Development
11.9 Apotex Inc.
11.9.1 Apotex Inc. Company Details
11.9.2 Apotex Inc. Business Overview and Its Total Revenue
11.9.3 Apotex Inc. Drugs for Treating Mental Disorders Introduction
11.9.4 Apotex Inc. Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.9.5 Apotex Inc. Recent Development
11.10 Mylan Pharmaceuticals
11.10.1 Mylan Pharmaceuticals Company Details
11.10.2 Mylan Pharmaceuticals Business Overview and Its Total Revenue
11.10.3 Mylan Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.10.4 Mylan Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.10.5 Mylan Pharmaceuticals Recent Development
11.11 Par Pharmaceutical
11.11.1 Par Pharmaceutical Company Details
11.11.2 Par Pharmaceutical Business Overview and Its Total Revenue
11.11.3 Par Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.11.4 Par Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.11.5 Par Pharmaceutical Recent Development
11.12 Aurobindo Pharma
11.12.1 Aurobindo Pharma Company Details
11.12.2 Aurobindo Pharma Business Overview and Its Total Revenue
11.12.3 Aurobindo Pharma Drugs for Treating Mental Disorders Introduction
11.12.4 Aurobindo Pharma Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.12.5 Aurobindo Pharma Recent Development
11.13 Torrent Pharmaceuticals
11.13.1 Torrent Pharmaceuticals Company Details
11.13.2 Torrent Pharmaceuticals Business Overview and Its Total Revenue
11.13.3 Torrent Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.13.4 Torrent Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.13.5 Torrent Pharmaceuticals Recent Development
11.14 Jubilant Lifesciences
11.14.1 Jubilant Lifesciences Company Details
11.14.2 Jubilant Lifesciences Business Overview and Its Total Revenue
11.14.3 Jubilant Lifesciences Drugs for Treating Mental Disorders Introduction
11.14.4 Jubilant Lifesciences Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.14.5 Jubilant Lifesciences Recent Development
11.15 Sun Pharmaceutical
11.15.1 Sun Pharmaceutical Company Details
11.15.2 Sun Pharmaceutical Business Overview and Its Total Revenue
11.15.3 Sun Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.15.4 Sun Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.15.5 Sun Pharmaceutical Recent Development
11.16 Sandoz (Novartis)
11.16.1 Sandoz (Novartis) Company Details
11.16.2 Sandoz (Novartis) Business Overview and Its Total Revenue
11.16.3 Sandoz (Novartis) Drugs for Treating Mental Disorders Introduction
11.16.4 Sandoz (Novartis) Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.16.5 Sandoz (Novartis) Recent Development
11.17 Hansoh Pharmaceutical
11.17.1 Hansoh Pharmaceutical Company Details
11.17.2 Hansoh Pharmaceutical Business Overview and Its Total Revenue
11.17.3 Hansoh Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.17.4 Hansoh Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.17.5 Hansoh Pharmaceutical Recent Development
11.18 WATSON Pharmaceuticals
11.18.1 WATSON Pharmaceuticals Company Details
11.18.2 WATSON Pharmaceuticals Business Overview and Its Total Revenue
11.18.3 WATSON Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.18.4 WATSON Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.18.5 WATSON Pharmaceuticals Recent Development
11.19 Zhejiang Langhua Pharmaceuticals
11.19.1 Zhejiang Langhua Pharmaceuticals Company Details
11.19.2 Zhejiang Langhua Pharmaceuticals Business Overview and Its Total Revenue
11.19.3 Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.19.4 Zhejiang Langhua Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.19.5 Zhejiang Langhua Pharmaceuticals Recent Development
11.20 Forest Laboratories
11.20.1 Forest Laboratories Company Details
11.20.2 Forest Laboratories Business Overview and Its Total Revenue
11.20.3 Forest Laboratories Drugs for Treating Mental Disorders Introduction
11.20.4 Forest Laboratories Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.20.5 Forest Laboratories Recent Development
11.21 H.Lundbeck A/S
11.21.1 H.Lundbeck A/S Company Details
11.21.2 H.Lundbeck A/S Business Overview and Its Total Revenue
11.21.3 H.Lundbeck A/S Drugs for Treating Mental Disorders Introduction
11.21.4 H.Lundbeck A/S Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.21.5 H.Lundbeck A/S Recent Development
11.22 Amneal Pharmaceuticals
11.22.1 Amneal Pharmaceuticals Company Details
11.22.2 Amneal Pharmaceuticals Business Overview and Its Total Revenue
11.22.3 Amneal Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.22.4 Amneal Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.22.5 Amneal Pharmaceuticals Recent Development
11.23 Hetero Drugs
11.23.1 Hetero Drugs Company Details
11.23.2 Hetero Drugs Business Overview and Its Total Revenue
11.23.3 Hetero Drugs Drugs for Treating Mental Disorders Introduction
11.23.4 Hetero Drugs Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.23.5 Hetero Drugs Recent Development
11.24 Macleods Pharmaceuticals
11.24.1 Macleods Pharmaceuticals Company Details
11.24.2 Macleods Pharmaceuticals Business Overview and Its Total Revenue
11.24.3 Macleods Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.24.4 Macleods Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.24.5 Macleods Pharmaceuticals Recent Development
11.25 Silarx Pharmacueticals
11.25.1 Silarx Pharmacueticals Company Details
11.25.2 Silarx Pharmacueticals Business Overview and Its Total Revenue
11.25.3 Silarx Pharmacueticals Drugs for Treating Mental Disorders Introduction
11.25.4 Silarx Pharmacueticals Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.25.5 Silarx Pharmacueticals Recent Development
11.26 Hikma Pharmaceuticals
11.26.1 Hikma Pharmaceuticals Company Details
11.26.2 Hikma Pharmaceuticals Business Overview and Its Total Revenue
11.26.3 Hikma Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.26.4 Hikma Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.26.5 Hikma Pharmaceuticals Recent Development
11.27 Lupin Limited
11.27.1 Lupin Limited Company Details
11.27.2 Lupin Limited Business Overview and Its Total Revenue
11.27.3 Lupin Limited Drugs for Treating Mental Disorders Introduction
11.27.4 Lupin Limited Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.27.5 Lupin Limited Recent Development
11.28 Prinston Pharmaceutical
11.28.1 Prinston Pharmaceutical Company Details
11.28.2 Prinston Pharmaceutical Business Overview and Its Total Revenue
11.28.3 Prinston Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.28.4 Prinston Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.28.5 Prinston Pharmaceutical Recent Development
11.29 STI Pharma
11.29.1 STI Pharma Company Details
11.29.2 STI Pharma Business Overview and Its Total Revenue
11.29.3 STI Pharma Drugs for Treating Mental Disorders Introduction
11.29.4 STI Pharma Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
11.29.5 STI Pharma Recent Development
12 Analyst's Viewpoints/Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Drugs for Treating Mental Disorders Market Size Growth Rate by Type (US$ Million): 2016 VS 2021 VS 2027
    Table 2. Key Players of Tablets
    Table 3. Key Players of Capsule
    Table 4. Key Players of Injection
    Table 5. Key Players of Solution
    Table 6. Key Players of Other
    Table 7. Global Drugs for Treating Mental Disorders Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Drugs for Treating Mental Disorders Market Size by Region (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Drugs for Treating Mental Disorders Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Drugs for Treating Mental Disorders Market Share by Regions (2016-2021)
    Table 11. Global Drugs for Treating Mental Disorders Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Drugs for Treating Mental Disorders Market Share by Regions (2022-2027)
    Table 13. Drugs for Treating Mental Disorders Market Trends
    Table 14. Drugs for Treating Mental Disorders Market Drivers
    Table 15. Drugs for Treating Mental Disorders Market Challenges
    Table 16. Drugs for Treating Mental Disorders Market Restraints
    Table 17. Ranking of Global Top Drugs for Treating Mental Disorders Manufacturers by Revenue (US$ Million) in 2020
    Table 18. Global Drugs for Treating Mental Disorders Revenue by Players (2016-2021) & (US$ Million)
    Table 19. Global Drugs for Treating Mental Disorders Market Share by Players (2016-2021)
    Table 20. Global Top Drugs for Treating Mental Disorders Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Treating Mental Disorders as of 2020)
    Table 21. Global 5 Largest Players Market Share by Drugs for Treating Mental Disorders Revenue (CR5 and HHI) (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Drugs for Treating Mental Disorders Product Solution and Service
    Table 24. Date of Enter into Drugs for Treating Mental Disorders Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Drugs for Treating Mental Disorders Market Size by Type (2016-2021) & (US$ Million)
    Table 27. Global Drugs for Treating Mental Disorders Revenue Market Share by Type (2016-2021)
    Table 28. Global Drugs for Treating Mental Disorders Forecasted Market Size by Type (2022-2027) & (US$ Million)
    Table 29. Global Drugs for Treating Mental Disorders Revenue Market Share by Type (2022-2027)
    Table 30. Global Drugs for Treating Mental Disorders Market Size by Application (2016-2021) & (US$ Million)
    Table 31. Global Drugs for Treating Mental Disorders Revenue Market Share by Application (2016-2021)
    Table 32. Global Drugs for Treating Mental Disorders Forecasted Market Size by Application (2022-2027) & (US$ Million)
    Table 33. Global Drugs for Treating Mental Disorders Revenue Market Share by Application (2022-2027)
    Table 34. Key Players Drugs for Treating Mental Disorders Revenue in North America (2020-2021) (US$ Million)
    Table 35. North America Drugs for Treating Mental Disorders Market Size by Countries (2016-2021) & (US$ Million)
    Table 36. North America Drugs for Treating Mental Disorders Market Size Share by Countries (2016-2021)
    Table 37. North America Drugs for Treating Mental Disorders Market Size by Countries (2022-2027) & (US$ Million)
    Table 38. North America Drugs for Treating Mental Disorders Market Size Share by Countries (2022-2027)
    Table 39. Drugs for Treating Mental Disorders Market Size (US$ Million) in U.S., Breakdown by Type (2016-2021)
    Table 40. Drugs for Treating Mental Disorders Market Size (US$ Million) in U.S., Breakdown by Type (2022-2027)
    Table 41. Drugs for Treating Mental Disorders Market Size (US$ Million) in U.S., Breakdown by Application (2016-2021)
    Table 42. Drugs for Treating Mental Disorders Market Size (US$ Million) in U.S., Breakdown by Application (2022-2027)
    Table 43. Drugs for Treating Mental Disorders Market Size (US$ Million) in Canada, Breakdown by Type (2016-2021)
    Table 44. Drugs for Treating Mental Disorders Market Size (US$ Million) in Canada, Breakdown by Type (2022-2027)
    Table 45. Drugs for Treating Mental Disorders Market Size (US$ Million) in Canada, Breakdown by Application (2016-2021)
    Table 46. Drugs for Treating Mental Disorders Market Size (US$ Million) in Canada, Breakdown by Application (2022-2027)
    Table 47. Key Players Drugs for Treating Mental Disorders Revenue in Europe (2020-2021) (US$ Million)
    Table 48. Europe Drugs for Treating Mental Disorders Market Size by Countries (2016-2021) & (US$ Million)
    Table 49. Europe Drugs for Treating Mental Disorders Market Size Share by Countries (2016-2021)
    Table 50. Europe Drugs for Treating Mental Disorders Market Size by Countries (2022-2027) & (US$ Million)
    Table 51. Europe Drugs for Treating Mental Disorders Market Size Share by Countries (2022-2027)
    Table 52. Drugs for Treating Mental Disorders Market Size (US$ Million) in Germany, Breakdown by Type (2016-2021)
    Table 53. Drugs for Treating Mental Disorders Market Size (US$ Million) in Germany, Breakdown by Type (2022-2027)
    Table 54. Drugs for Treating Mental Disorders Market Size (US$ Million) in Germany, Breakdown by Application (2016-2021)
    Table 55. Drugs for Treating Mental Disorders Market Size (US$ Million) in Germany, Breakdown by Application (2022-2027)
    Table 56. Drugs for Treating Mental Disorders Market Size (US$ Million) in France, Breakdown by Type (2016-2021)
    Table 57. Drugs for Treating Mental Disorders Market Size (US$ Million) in France, Breakdown by Type (2022-2027)
    Table 58. Drugs for Treating Mental Disorders Market Size (US$ Million) in France, Breakdown by Application (2016-2021)
    Table 59. Drugs for Treating Mental Disorders Market Size (US$ Million) in France, Breakdown by Application (2022-2027)
    Table 60. Drugs for Treating Mental Disorders Market Size (US$ Million) in U.K., Breakdown by Type (2016-2021)
    Table 61. Drugs for Treating Mental Disorders Market Size (US$ Million) in U.K., Breakdown by Type (2022-2027)
    Table 62. Drugs for Treating Mental Disorders Market Size (US$ Million) in U.K., Breakdown by Application (2016-2021)
    Table 63. Drugs for Treating Mental Disorders Market Size (US$ Million) in U.K., Breakdown by Application (2022-2027)
    Table 64. Drugs for Treating Mental Disorders Market Size (US$ Million) in Italy, Breakdown by Type (2016-2021)
    Table 65. Drugs for Treating Mental Disorders Market Size (US$ Million) in Italy, Breakdown by Type (2022-2027)
    Table 66. Drugs for Treating Mental Disorders Market Size (US$ Million) in Italy, Breakdown by Application (2016-2021)
    Table 67. Drugs for Treating Mental Disorders Market Size (US$ Million) in Italy, Breakdown by Application (2022-2027)
    Table 68. Drugs for Treating Mental Disorders Market Size (US$ Million) in Russia, Breakdown by Type (2016-2021)
    Table 69. Drugs for Treating Mental Disorders Market Size (US$ Million) in Russia, Breakdown by Type (2022-2027)
    Table 70. Drugs for Treating Mental Disorders Market Size (US$ Million) in Russia, Breakdown by Application (2016-2021)
    Table 71. Drugs for Treating Mental Disorders Market Size (US$ Million) in Russia, Breakdown by Application (2022-2027)
    Table 72. Key Players Drugs for Treating Mental Disorders Revenue in Asia-Pacific (2020-2021) (US$ Million)
    Table 73. Asia-Pacific Drugs for Treating Mental Disorders Market Size by Regions (2016-2021) & (US$ Million)
    Table 74. Asia-Pacific Drugs for Treating Mental Disorders Market Size by Regions (2022-2027) & (US$ Million)
    Table 75. Drugs for Treating Mental Disorders Market Size (US$ Million) in China, Breakdown by Type (2016-2021)
    Table 76. Drugs for Treating Mental Disorders Market Size (US$ Million) in China, Breakdown by Type (2022-2027)
    Table 77. Drugs for Treating Mental Disorders Market Size (US$ Million) in China, Breakdown by Application (2016-2021)
    Table 78. Drugs for Treating Mental Disorders Market Size (US$ Million) in China, Breakdown by Application (2022-2027)
    Table 79. Drugs for Treating Mental Disorders Market Size (US$ Million) in Japan, Breakdown by Type (2016-2021)
    Table 80. Drugs for Treating Mental Disorders Market Size (US$ Million) in Japan, Breakdown by Type (2022-2027)
    Table 81. Drugs for Treating Mental Disorders Market Size (US$ Million) in Japan, Breakdown by Application (2016-2021)
    Table 82. Drugs for Treating Mental Disorders Market Size (US$ Million) in Japan, Breakdown by Application (2022-2027)
    Table 83. Drugs for Treating Mental Disorders Market Size (US$ Million) in South Korea, Breakdown by Type (2016-2021)
    Table 84. Drugs for Treating Mental Disorders Market Size (US$ Million) in South Korea, Breakdown by Type (2022-2027)
    Table 85. Drugs for Treating Mental Disorders Market Size (US$ Million) in South Korea, Breakdown by Application (2016-2021)
    Table 86. Drugs for Treating Mental Disorders Market Size (US$ Million) in South Korea, Breakdown by Application (2022-2027)
    Table 87. Drugs for Treating Mental Disorders Market Size (US$ Million) in India, Breakdown by Type (2016-2021)
    Table 88. Drugs for Treating Mental Disorders Market Size (US$ Million) in India, Breakdown by Type (2022-2027)
    Table 89. Drugs for Treating Mental Disorders Market Size (US$ Million) in India, Breakdown by Application (2016-2021)
    Table 90. Drugs for Treating Mental Disorders Market Size (US$ Million) in India, Breakdown by Application (2022-2027)
    Table 91. Drugs for Treating Mental Disorders Market Size (US$ Million) in Australia, Breakdown by Type (2016-2021)
    Table 92. Drugs for Treating Mental Disorders Market Size (US$ Million) in Australia, Breakdown by Type (2022-2027)
    Table 93. Drugs for Treating Mental Disorders Market Size (US$ Million) in Australia, Breakdown by Application (2016-2021)
    Table 94. Drugs for Treating Mental Disorders Market Size (US$ Million) in Australia, Breakdown by Application (2022-2027)
    Table 95. Drugs for Treating Mental Disorders Market Size (US$ Million) in Taiwan, Breakdown by Type (2016-2021)
    Table 96. Drugs for Treating Mental Disorders Market Size (US$ Million) in Taiwan, Breakdown by Type (2022-2027)
    Table 97. Drugs for Treating Mental Disorders Market Size (US$ Million) in Taiwan, Breakdown by Application (2016-2021)
    Table 98. Drugs for Treating Mental Disorders Market Size (US$ Million) in Taiwan, Breakdown by Application (2022-2027)
    Table 99. Drugs for Treating Mental Disorders Market Size (US$ Million) in Indonesia, Breakdown by Type (2016-2021)
    Table 100. Drugs for Treating Mental Disorders Market Size (US$ Million) in Indonesia, Breakdown by Type (2022-2027)
    Table 101. Drugs for Treating Mental Disorders Market Size (US$ Million) in Indonesia, Breakdown by Application (2016-2021)
    Table 102. Drugs for Treating Mental Disorders Market Size (US$ Million) in Indonesia, Breakdown by Application (2022-2027)
    Table 103. Key Players Drugs for Treating Mental Disorders Revenue in Latin America (2020-2021) (US$ Million)
    Table 104. Latin America Drugs for Treating Mental Disorders Market Size by Countries (2016-2021) & (US$ Million)
    Table 105. Latin America Drugs for Treating Mental Disorders Market Size by Countries (2022-2027) & (US$ Million)
    Table 106. Drugs for Treating Mental Disorders Market Size (US$ Million) in Mexico, Breakdown by Type (2016-2021)
    Table 107. Drugs for Treating Mental Disorders Market Size (US$ Million) in Mexico, Breakdown by Type (2022-2027)
    Table 108. Drugs for Treating Mental Disorders Market Size (US$ Million) in Mexico, Breakdown by Application (2016-2021)
    Table 109. Drugs for Treating Mental Disorders Market Size (US$ Million) in Mexico, Breakdown by Application (2022-2027)
    Table 110. Drugs for Treating Mental Disorders Market Size (US$ Million) in Brazil, Breakdown by Type (2016-2021)
    Table 111. Drugs for Treating Mental Disorders Market Size (US$ Million) in Brazil, Breakdown by Type (2022-2027)
    Table 112. Drugs for Treating Mental Disorders Market Size (US$ Million) in Brazil, Breakdown by Application (2016-2021)
    Table 113. Drugs for Treating Mental Disorders Market Size (US$ Million) in Brazil, Breakdown by Application (2022-2027)
    Table 114. Drugs for Treating Mental Disorders Market Size (US$ Million) in Argentina, Breakdown by Type (2016-2021)
    Table 115. Drugs for Treating Mental Disorders Market Size (US$ Million) in Argentina, Breakdown by Type (2022-2027)
    Table 116. Drugs for Treating Mental Disorders Market Size (US$ Million) in Argentina, Breakdown by Application (2016-2021)
    Table 117. Drugs for Treating Mental Disorders Market Size (US$ Million) in Argentina, Breakdown by Application (2022-2027)
    Table 118. Key Players Drugs for Treating Mental Disorders Revenue in Middle East & Africa (2020-2021) (US$ Million)
    Table 119. Middle East & Africa Drugs for Treating Mental Disorders Market Size by Countries (2016-2021) & (US$ Million)
    Table 120. Middle East & Africa Drugs for Treating Mental Disorders Market Size by Countries (2022-2027) & (US$ Million)
    Table 121. Drugs for Treating Mental Disorders Market Size (US$ Million) in Turkey, Breakdown by Type (2016-2021)
    Table 122. Drugs for Treating Mental Disorders Market Size (US$ Million) in Turkey, Breakdown by Type (2022-2027)
    Table 123. Drugs for Treating Mental Disorders Market Size (US$ Million) in Turkey, Breakdown by Application (2016-2021)
    Table 124. Drugs for Treating Mental Disorders Market Size (US$ Million) in Turkey, Breakdown by Application (2022-2027)
    Table 125. Drugs for Treating Mental Disorders Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2016-2021)
    Table 126. Drugs for Treating Mental Disorders Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2022-2027)
    Table 127. Drugs for Treating Mental Disorders Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2016-2021)
    Table 128. Drugs for Treating Mental Disorders Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2022-2027)
    Table 129. Drugs for Treating Mental Disorders Market Size (US$ Million) in UAE, Breakdown by Type (2016-2021)
    Table 130. Drugs for Treating Mental Disorders Market Size (US$ Million) in UAE, Breakdown by Type (2022-2027)
    Table 131. Drugs for Treating Mental Disorders Market Size (US$ Million) in UAE, Breakdown by Application (2016-2021)
    Table 132. Drugs for Treating Mental Disorders Market Size (US$ Million) in UAE, Breakdown by Application (2022-2027)
    Table 133. Johnson and Johnson Company Details
    Table 134. Johnson and Johnson Business Overview
    Table 135. Johnson and Johnson Revenue in Drugs for Treating Mental Disorders Business (2016-2021) & (US$ Million)
    Table 136. Johnson and Johnson Drugs for Treating Mental Disorders Drugs for Treating Mental Disorders Product
    Table 137. Johnson and Johnson Recent Development
    Table 138. Pfizer Company Details
    Table 139. Pfizer Business Overview
    Table 140. Pfizer Revenue in Drugs for Treating Mental Disorders Business (2016-2021) & (US$ Million)
    Table 141. Pfizer Drugs for Treating Mental Disorders Product
    Table 142. Pfizer Recent Development
    Table 143. Eli Lilly Company Details
    Table 144. Eli Lilly Business Overview
    Table 145. Eli Lilly Revenue in Drugs for Treating Mental Disorders Business (2016-2021) & (US$ Million)
    Table 146. Eli Lilly Drugs for Treating Mental Disorders Product
    Table 147. Eli Lilly Recent Development
    Table 148. GlaxoSmithKline Company Details
    Table 149. GlaxoSmithKline Business Overview
    Table 150. GlaxoSmithKline Revenue in Drugs for Treating Mental Disorders Business (2016-2021) & (US$ Million)
    Table 151. GlaxoSmithKline Drugs for Treating Mental Disorders Product
    Table 152. GlaxoSmithKline Recent Development
    Table 153. AstraZeneca Company Details
    Table 154. AstraZeneca Business Overview
    Table 155. AstraZeneca Revenue in Drugs for Treating Mental Disorders Business (2016-2021) & (US$ Million)
    Table 156. AstraZeneca Drugs for Treating Mental Disorders Product
    Table 157. AstraZeneca Recent Development
    Table 158. Bristol-Myers Squibb Company Details
    Table 159. Bristol-Myers Squibb Business Overview
    Table 160. Bristol-Myers Squibb Revenue in Drugs for Treating Mental Disorders Business (2016-2021) & (US$ Million)
    Table 161. Bristol-Myers Squibb Drugs for Treating Mental Disorders Product
    Table 162. Bristol-Myers Squibb Recent Development
    Table 163. Teva Pharmaceutical Company Details
    Table 164. Teva Pharmaceutical Business Overview
    Table 165. Teva Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2016-2021) & (US$ Million)
    Table 166. Teva Pharmaceutical Drugs for Treating Mental Disorders Product
    Table 167. Teva Pharmaceutical Recent Development
    Table 168. Dr. Reddy's Laboratories Company Details
    Table 169. Dr. Reddy's Laboratories Business Overview
    Table 170. Dr. Reddy's Laboratories Revenue in Drugs for Treating Mental Disorders Business (2016-2021) & (US$ Million)
    Table 171. Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Product
    Table 172. Dr. Reddy's Laboratories Recent Development
    Table 173. Apotex Inc. Company Details
    Table 174. Apotex Inc. Business Overview
    Table 175. Apotex Inc. Revenue in Drugs for Treating Mental Disorders Business (2016-2021) & (US$ Million)
    Table 176. Apotex Inc. Drugs for Treating Mental Disorders Product
    Table 177. Apotex Inc. Recent Development
    Table 178. Mylan Pharmaceuticals Company Details
    Table 179. Mylan Pharmaceuticals Business Overview
    Table 180. Mylan Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2016-2021) & (US$ Million)
    Table 181. Mylan Pharmaceuticals Drugs for Treating Mental Disorders Product
    Table 182. Mylan Pharmaceuticals Recent Development
    Table 183. Par Pharmaceutical Company Details
    Table 184. Par Pharmaceutical Business Overview
    Table 185. Par Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2016-2021) & (US$ Million)
    Table 186. Par Pharmaceutical Drugs for Treating Mental Disorders Product
    Table 187. Par Pharmaceutical Recent Development
    Table 188. Aurobindo Pharma Company Details
    Table 189. Aurobindo Pharma Business Overview
    Table 190. Aurobindo Pharma Revenue in Drugs for Treating Mental Disorders Business (2016-2021) & (US$ Million)
    Table 191. Aurobindo Pharma Drugs for Treating Mental Disorders Product
    Table 192. Aurobindo Pharma Recent Development
    Table 193. Torrent Pharmaceuticals Company Details
    Table 194. Torrent Pharmaceuticals Business Overview
    Table 195. Torrent Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2016-2021) & (US$ Million)
    Table 196. Torrent Pharmaceuticals Drugs for Treating Mental Disorders Product
    Table 197. Torrent Pharmaceuticals Recent Development
    Table 198. Jubilant Lifesciences Company Details
    Table 199. Jubilant Lifesciences Business Overview
    Table 200. Jubilant Lifesciences Revenue in Drugs for Treating Mental Disorders Business (2016-2021) & (US$ Million)
    Table 201. Jubilant Lifesciences Drugs for Treating Mental Disorders Product
    Table 202. Jubilant Lifesciences Recent Development
    Table 203. Sun Pharmaceutical Company Details
    Table 204. Sun Pharmaceutical Business Overview
    Table 205. Sun Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2016-2021) & (US$ Million)
    Table 206. Sun Pharmaceutical Drugs for Treating Mental Disorders Product
    Table 207. Sun Pharmaceutical Recent Development
    Table 208. Sandoz (Novartis) Company Details
    Table 209. Sandoz (Novartis) Business Overview
    Table 210. Sandoz (Novartis) Revenue in Drugs for Treating Mental Disorders Business (2016-2021) & (US$ Million)
    Table 211. Sandoz (Novartis) Drugs for Treating Mental Disorders Product
    Table 212. Sandoz (Novartis) Recent Development
    Table 213. Hansoh Pharmaceutical Company Details
    Table 214. Hansoh Pharmaceutical Business Overview
    Table 215. Hansoh Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2016-2021) & (US$ Million)
    Table 216. Hansoh Pharmaceutical Drugs for Treating Mental Disorders Product
    Table 217. Hansoh Pharmaceutical Recent Development
    Table 218. WATSON Pharmaceuticals Company Details
    Table 219. WATSON Pharmaceuticals Business Overview
    Table 220. WATSON Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2016-2021) & (US$ Million)
    Table 221. WATSON Pharmaceuticals Drugs for Treating Mental Disorders Product
    Table 222. WATSON Pharmaceuticals Recent Development
    Table 223. Zhejiang Langhua Pharmaceuticals Company Details
    Table 224. Zhejiang Langhua Pharmaceuticals Business Overview
    Table 225. Zhejiang Langhua Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2016-2021) & (US$ Million)
    Table 226. Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Product
    Table 227. Zhejiang Langhua Pharmaceuticals Recent Development
    Table 228. Forest Laboratories Company Details
    Table 229. Forest Laboratories Business Overview
    Table 230. Forest Laboratories Revenue in Drugs for Treating Mental Disorders Business (2016-2021) & (US$ Million)
    Table 231. Forest Laboratories Drugs for Treating Mental Disorders Product
    Table 232. Forest Laboratories Recent Development
    Table 233. H.Lundbeck A/S Company Details
    Table 234. Amneal Pharmaceuticals Company Details
    Table 235. Hetero Drugs Company Details
    Table 236. Macleods Pharmaceuticals Company Details
    Table 237. Silarx Pharmacueticals Company Details
    Table 238. Hikma Pharmaceuticals Company Details
    Table 239. Lupin Limited Company Details
    Table 240. Prinston Pharmaceutical Company Details
    Table 241. STI Pharma Company Details
    Table 242. Research Programs/Design for This Report
    Table 243. Key Data Information from Secondary Sources
    Table 244. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Drugs for Treating Mental Disorders Market Share by Type: 2020 & 2027
    Figure 2. Tablets Features
    Figure 3. Capsule Features
    Figure 4. Injection Features
    Figure 5. Solution Features
    Figure 6. Other Features
    Figure 7. Global Drugs for Treating Mental Disorders Market Share by Application: 2020 & 2027
    Figure 8. Antipsychotics Case Studies
    Figure 9. Antidepressants Case Studies
    Figure 10. Antianxiety (Anxiolyitcs) Case Studies
    Figure 11. Anti-Seizure Medications Case Studies
    Figure 12. Stimulants Case Studies
    Figure 13. Cognitive Disorders And Dementia Case Studies
    Figure 14. Sleep Disorder Treatments Case Studies
    Figure 15. Substance Abuse Treatments Case Studies
    Figure 16. Hypnosis And Tranquilizers Case Studies
    Figure 17. Drugs for Treating Mental Disorders Report Years Considered
    Figure 18. Global Drugs for Treating Mental Disorders Market Share by Regions: 2016 VS 2021 VS 2027
    Figure 19. Global Drugs for Treating Mental Disorders Market Size YoY Growth 2016-2027 (US$ Million)
    Figure 20. Global Drugs for Treating Mental Disorders Market Share by Regions (2022-2027)
    Figure 21. Global Drugs for Treating Mental Disorders Market Share by Players in 2020
    Figure 22. Global Top Drugs for Treating Mental Disorders Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Treating Mental Disorders as of 2020)
    Figure 23. The Top 10 and 5 Players Market Share by Drugs for Treating Mental Disorders Revenue in 2020
    Figure 24. North America Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. U.S. Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Germany Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Asia-Pacific Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. China Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Japan Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. South Korea Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. India Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Australia Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Taiwan Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Indonesia Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Thailand Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Malaysia Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Philippines Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Vietnam Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Mexico Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Brazil Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Argentina Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Middle East & Africa Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Turkey Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Saudi Arabia Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. UAE Drugs for Treating Mental Disorders Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$6600
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$9900
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$13200
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension

RELATED REPORTS

Global and China Bipolar Disorder Market Size Status and Forecast 2021 2027
Global and China Bipolar Disorder Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-25G6547
Thu Sep 02 00:00:00 UTC 2021

Add to Cart

Global Chronic Depressive Personality Disorder Treatment Market Size Status and Forecast 2021 2027
Global Chronic Depressive Personality Disorder Treatment Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-36F6040
Tue Aug 10 00:00:00 UTC 2021

Add to Cart

Global Abilify Maintena Sales Market Report 2021
Global Abilify Maintena Sales Market Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-21C6167
Tue Aug 10 00:00:00 UTC 2021

Add to Cart

Global Dysthymia Clinical Trial Market Size Status and Forecast 2021 2027
Global Dysthymia Clinical Trial Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-2P6528
Tue Aug 10 00:00:00 UTC 2021

Add to Cart